Thomas McCourt - Chief Executive Officer, Ironwood Pharmaceuticals Inc

As of May 25, 2022


What is Thomas McCourt's Net Worth?

The current estimated net worth of Ironwood Pharmaceuticals Inc's Chief Executive Officer, Thomas McCourt, is estimated to be about $12.35M . Thomas McCourt owns about 798,881 units of Ironwood Pharmaceuticals Inc common stock. In the last 12 years at Ironwood Pharmaceuticals Inc, Thomas McCourt has sold an estimated value of $7.6M worth.

What is Thomas McCourt's Past Insider Trading?

Thomas McCourt's largest purchase order was 220,000 units , worth over $1.07M on September 4, 2019. Thomas McCourt's largest sale order was 220,000 units , worth over $2.03M on September 4, 2019. In total, Thomas McCourt has made about 39 transactions over 12 years of their time at Ironwood Pharmaceuticals Inc. Thomas McCourt usually trades in March and February, with the busiest year in 2019. The most recent transaction was a sale order of 36,308 units , worth over $417.54K on May 25, 2022.

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What was Thomas McCourt's Salary in 2020?

As Chief Executive Officer of Ironwood Pharmaceuticals Inc, Thomas McCourt has a total base salary of $576,120 . Thomas McCourt received compensation valued at about $3,409,896 in 2020 after becoming Chief Executive Officer. The vast majority of their compensation came in the form of stock awards of $2,465,327 , other earnings, plans or compensations of $357,409 , and other compensation of $11,040 .

What is Thomas McCourt's' Mailing Address?

  • Mailing address is C/o Ironwood Pharmaceuticals, Inc. 100 Summer Street, Suite 2300 Boston MA 02110 MA

Ironwood Pharmaceuticals Inc Executive Compensation

Name
Year
Salary
Bonus
Stock Awards
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Total
Mark Mallon* 2020 $801,173 - $5,423,731 - $585,169 $11,040 $6,821,113
Mark Mallon* 2019 $750,000 $880,000 $3,692,810 $3,804,331 $797,063 $144,596 $10,068,800
Mark Mallon* 2018 - - - - - - -
Gina Consylman 2020 $512,751 - $1,676,402 - $264,652 $11,040 $2,464,845
Gina Consylman 2019 $480,000 $250,000 $1,467,731 $888,546 $358,800 $8,502 $3,453,579
Gina Consylman 2018 $415,000 - $782,385 $501,764 $207,500 $8,040 $1,914,688
Thomas McCourt* 2020 $576,120 - $2,465,327 - $357,409 $11,040 $3,409,896
Thomas McCourt* 2019 $511,250 - $1,760,143 $2,370,159 $454,272 $8,502 $5,104,327
Thomas McCourt* 2018 $465,000 - $549,641 $869,479 $232,500 $34,002 $2,150,622
Jason Rickard 2020 $473,314 - $1,479,191 - $258,338 $11,040 $2,221,883
Jason Rickard 2019 - - - - - - -
Jason Rickard 2018 - - - - - - -
Michael Shetzline, M.D., Ph.D. 2020 $464,681 $100,000 $1,121,001 - $194,558 $11,040 $1,891,310
Michael Shetzline, M.D., Ph.D. 2019 - - - - - - -
Michael Shetzline, M.D., Ph.D. 2018 - - - - - - -
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1446847/000104746921001006/a2243150zdef14a.htm

What are Ironwood Pharmaceuticals Inc's Past Insider Trades?

Ironwood Pharmaceuticals Inc's most recent insider trade came on June 16, 2022 by Marla Kessler who sold 7,610 units worth $88.66K . In the last 12 years, insiders at Ironwood Pharmaceuticals Inc have sold an estimated value of $111.61M and bought an estimated value of $40.6M worth of shares. Insider trading is most common in June, with the busiest year in 2019. The most active traders at the company are Mark Currie, Director,  Bryan E Roberts, Director,  and Thomas McCourt, Chief Executive Officer .

IRONWOOD PHARMACEUTICALS INC Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1